Home
Conditions
Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Clinical trial condition

Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Explore clinical trials studying Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity. Study availability and eligibility vary by location and protocol.

14 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity trial results

Completed

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

NCT03422536

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +41 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

Yale Cancer Center New Haven, Connecticut, United States

Moffitt Cancer Center Tampa, Florida, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

View Trial Details

Completed

Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

NCT01044433

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +30 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00055913

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +18 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

NCT01316757

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Univesity of Rochester Medical Center Rochester, New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00387335

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00098631

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +21 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

NCT00055770

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity trial results

Related conditions